(Q47980435)

7 February 2018

editorial

0 references

title

Mea Culpa with cancer-targeted therapy: new thinking and new agents design for novel, causal networks-based, personalized biomedicine (English)

1 reference

7 February 2018

0 references

1

1 reference

7 February 2018

publication date

1 April 2009

1 reference

7 February 2018

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

published in

1 reference

7 February 2018

volume

9

1 reference

7 February 2018

issue

3

1 reference

7 February 2018

page(s)

217-221

1 reference

7 February 2018

Global cancer statistics, 2002

cites work

1 reference

Current and future utilization of services from medical oncologists

21 January 2018

1 reference

Quo vadis with targeted drugs in the 21st century?

21 January 2018

1 reference

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

The distinctive nature of HER2-positive breast cancers

21 January 2018

1 reference

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

21 January 2018

1 reference

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

21 January 2018

1 reference

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial

21 January 2018

1 reference

EGFR antagonists in cancer treatment

21 January 2018

1 reference

Epidermal growth factor receptor tyrosine kinase inhibitors plus chemotherapy: case closed or is the jury still out?

21 January 2018

1 reference

Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer

21 January 2018

1 reference

Targeting EGFR in colorectal cancer.

21 January 2018

1 reference

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer

21 January 2018

1 reference

Trial offers early test case for personalized medicine

21 January 2018

1 reference

The genomic landscapes of human breast and colorectal cancers

21 January 2018

1 reference

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

21 January 2018

1 reference

Genome-wide association studies in cancer.

21 January 2018

1 reference

Reverse engineering the genotype-phenotype map with natural genetic variation

21 January 2018

1 reference

21 January 2018

Quantitative genetics

1 reference

The loci of evolution: how predictable is genetic evolution?

21 January 2018

1 reference

Genetic screening for signal transduction in the era of network biology

21 January 2018

1 reference

Progress and challenges in genome-wide association studies in humans

21 January 2018

1 reference

Gene-environment interaction in yeast gene expression

21 January 2018

1 reference

Targeting cancer with small molecule kinase inhibitors

21 January 2018

1 reference

From signals to patterns: space, time, and mathematics in developmental biology

21 January 2018

1 reference

Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networks

21 January 2018

1 reference

Assessing both genetic variation (SNPs/CNVs) and gene-environment interactions may lead to personalized gastric cancer prevention

21 January 2018

1 reference

Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery

21 January 2018

1 reference

In silico cancer modeling: is it ready for prime time?

21 January 2018

1 reference

PI3K pathway alterations in cancer: variations on a theme

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERM.09.7

1 reference

7 February 2018

1 reference

7 February 2018